v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (33,941,345) $ (24,391,594)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 534,670 405,450
Stock-based compensation 5,918,055 5,481,938
Restricted stock awards granted   257,461
Amortization/accretion of note premiums/discounts (358,625)  
Changes in lease liabilities 641,285 (16,844)
Other (6,591) 150,673
Changes in operating assets and liabilities:    
Receivables 59,167 10,308,655
Prepaid expenses and other assets 979,776 55,473
Accounts payable and accrued expenses (3,081,283) 1,315,268
Net cash used in operating activities (29,254,891) (6,433,520)
Cash flows from investing activities:    
Purchase of marketable securities (174,893,062) (18,181,600)
Proceeds from sales and maturities of marketable securities 30,998,448 43,212,559
Purchases of property and equipment (5,121,709) (896,007)
Payments for leasehold improvements (921,752) (244,279)
Payments for construction in progress (4,703,521)  
Net cash provided by (used in) investing activities (154,641,596) 23,890,673
Cash flows from financing activities:    
Proceeds from exercise of stock options 1,470,659 50,354
Net cash provided by financing activities 1,470,659 50,354
Net increase (decrease) in cash and cash equivalents (182,425,828) 17,507,507
Cash and cash equivalents balance at beginning of period 287,847,312 11,286,996
Cash and cash equivalents balance at end of period $ 105,421,484 $ 28,794,503